Albert M. Maguire
- Ophthalmology top 0.05%
- Retinal Diseases and Treatments 66
- Retinal and Optic Conditions 22
- Glaucoma and retinal disorders 19
- Genetics top 0.5%
- Virus-based gene therapy research 37
- Molecular Biology top 0.5%
- Retinal Development and Disorders 109
- CRISPR and Genetic Engineering 14
-
- Retinal and Macular Surgery 20
- Retinopathy of Prematurity Studies 16
- Co-authors
- Jean BennettTomás S. AlemánSamuel G. JacobsonArtur V. CideciyanVibha AnandGregory M. AclandJames M. WilsonGeoffrey K. Aguirre
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (3 papers)Journal of Clinical Investigation (3 papers)
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Albert M. Maguire
180 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Ophthalmology 4.7k
- Genetics 3.1k
- Molecular Biology 7.5k
- Radiology, Nuclear Medicine and Imaging 2.3k
- Cellular and Molecular Neuroscience 1.5k
Countries citing papers authored by Albert M. Maguire
This map shows the geographic impact of Albert M. Maguire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert M. Maguire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert M. Maguire more than expected).
Fields of papers citing papers by Albert M. Maguire
This network shows the impact of papers produced by Albert M. Maguire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert M. Maguire. The network helps show where Albert M. Maguire may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Albert M. Maguire, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gene Editing for CEP290 -Associated Retinal Degenerationbreakdown → | 2024 | 86 |
| 2 | 2023 | 21 | |
| 3 | Five-Year Post-Injection Results of the Phase 3 Trial of Voretigene Neparvovec-rzyl in Biallelic RPE65 Mutation-Associated Inherited Retinal Disease | 2021 | 3 |
| 4 | Short-term assessment of subfoveal injection of AAV2-hCHM gene augmentation in Choroideremia using adaptive optics ophthalmoscopy | 2020 | 2 |
| 5 | AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: 2 year Results of an Ongoing Phase I/II Gene Therapy Trial | 2019 | 5 |
| 6 | Cellular-scale assessment of visual function in Choroideremia | 2018 | 1 |
| 7 | Safety of subretinal delivery of RGX-314 (AAV8-anti-VEGF Fab) in the non-human primate as assessed by full-field ERG | 2018 | 1 |
| 8 | AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: Preliminary Six Month Safety Results of an Ongoing Phase I/II Gene Therapy Trial | 2017 | 4 |
| 9 | Correlation of multi-luminance mobility testing with visual function tests in a phase 3 trial of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease | 2017 | 3 |
| 10 | 2017 | 30 | |
| 11 | Year 2 results for a phase 3 trial of voretigene neparvovec in biallelic RPE65-mediated inherited retinal disease | 2017 | 6 |
| 12 | Subretinal delivery of RGX-314 AAV8-anti-VEGF Fab gene therapy in NHP | 2017 | 1 |
| 13 | 2016 | 89 | |
| 14 | Retinal structure - function comparison through adaptive optics imaging reveals disease pathogenesis in choroideremia | 2014 | 1 |
| 15 | Adaptive Optics Scanning Laser Ophthalmoscopy and Multi-Modality Clinical Imaging in a Patient with Gyrate Atrophy | 2013 | 1 |
| 16 | Cone And Rod Transduction With Alternative AAV Serotypes In The Macula Of Non-human Primates | 2011 | 4 |
| 17 | 2011 | 107 | |
| 18 | Gene Therapy of a Mouse Model of Stargardt's Disease Using Adeno-Associated Viral Vectors Packaging Large Genes | 2008 | 1 |
| 19 | Effect of over-expression of pigment epithelium derived factor (PEDF) on developing retinal vasculature in the mouse. | 2004 | 10 |
| 20 | The Age-Related Macular Degeneration Radiotherapy Trial (AMDRT): 1 Year Results | 2003 | 1 |
About Albert M. Maguire
Albert M. Maguire is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 183 papers that have together received 10.2k indexed citations. Recurring topics across this work include Retinal Development and Disorders (109 papers), Retinal Diseases and Treatments (66 papers), Virus-based gene therapy research (37 papers), Retinal and Optic Conditions (22 papers), Retinal and Macular Surgery (20 papers), Glaucoma and retinal disorders (19 papers), Retinopathy of Prematurity Studies (16 papers) and CRISPR and Genetic Engineering (14 papers). The work is most often cited by research in Ophthalmology (4.7k citations), Genetics (3.1k citations) and Molecular Biology (7.5k citations). Albert M. Maguire has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Jean Bennett, Tomás S. Alemán, Samuel G. Jacobson, Artur V. Cideciyan, Vibha Anand, Gregory M. Acland, James M. Wilson, Geoffrey K. Aguirre, Susan E. Pearce-Kelling and William W. Hauswirth. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.